Summit Trail Advisors »

Takeda Pharmaceutical shares owned by Summit Trail Advisors

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Summit Trail Advisors from 13F filings

Historical chart of Summit Trail Advisors investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Summit Trail Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Summit Trail Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $579k 31k 18.52

More positions owned by Summit Trail Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Floatng Rat Trea (USFR)
Broadcom (AVGO)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ollies Bargain Outlt Hldgs I (OLLI)
NVIDIA Corporation (NVDA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Dlocal Class A Com (DLO)
Amphenol Corp Cl A (APH)
Amazon (AMZN)

View all positions for Summit Trail Advisors

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Brandes Investment Partners
FMR
BlackRock
UBS Group
Renaissance Technologies
D. E. Shaw & Co
Van Eck Associates Corp.
Citadel Advisors
First Trust Advisors
Managed Asset Portfolios
Northern Trust

View all funds holding Takeda Pharmaceutical